When de novo-designed protein logics meet CAR-T therapies

Protein logic gates acting at posttranscriptional levels are unique in being amenable to the control of both intracellular and intercellular biological processes. In a recent paper published in Science, Lajoie et al. engineered highly versatile colocalization-dependent protein switch that are activated upon detection of logic combinations (e.g., AND, OR and NOT) of specific cell surface antigens, providing another important asset for "universal" CAR-T therapies.